glp-1 and dpp4 Prescribing pearls: A guide to DPP-4 inhibitors (gliptins) Glucagon-like peptide-1 - Wikipedia

[14] Sporadic Nausea The neurogenic origin of GLP-related nausea (and nausea in general) means that nausea can occur at seemingly random times, with no connection to food consumption

Currently, 28.7% of people in England are obese with a further 35.6% overweight [2]

Within this metabolic context, GLP-1RA therapy may create conditions in which reliance on lipid-derived substrates increases the functional importance of redox-buffering systems that maintain oxidative stability

Common side effects Genital and urinary tract infections Increased urination Nasopharyngitis (cold symptoms) Back pain Weight loss Nausea and constipation Serious risks Severe allergic reactions (hives, facial swelling, breathing difficulty) Hypoglycemia when combined with insulin or sulfonylureas Dehydration, acute kidney injury, hypotension Diabetic ketoacidosis Fourniers gangrene (rare perineal infection) Indications Type 2 diabetes mellitus (monotherapy or addon) Reduction of heart failurerelated hospitalizations Slowing progression of chronic kidney disease Accessing Farxiga Farxiga is available by prescription only